Literature DB >> 2195339

Immunocytochemical study of dystrophin at the myotendinous junction.

C E Samitt1, E Bonilla.   

Abstract

Dystrophin is the protein whose deficiency results in Duchenne muscular dystrophy. The protein has homologies with a number of cytoskeletal proteins, is localized at the muscle sarcolemma and it may provide stability to the muscle plasma membrane. Using immunocytochemical techniques, we have studied dystrophin localization at the myotendinous junction, a region of membrane complexity that requires more stability because it is subjected to great mechanical stress during the transmission of contractile force to the tendon. The results showed subsarcolemmal deposits of dystrophin at the junctional folds of the myotendon as well as membrane-associated dystrophin at extrajunctional sarcolemma. The findings suggest that dystrophin may be one of the components linking terminal actin filaments to the subplasmalemmal surface of the junctional folds of the myotendon.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2195339     DOI: 10.1002/mus.880130605

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  28 in total

1.  Ultrastructural comparison of slack and stretched myotendinous junctions, based on a three-dimensional model of the connecting domain.

Authors:  D J Law
Journal:  J Muscle Res Cell Motil       Date:  1993-08       Impact factor: 2.698

Review 2.  The dystrophin superfamily: variability and complexity.

Authors:  E Fabbrizio; F Pons; A Robert; G Hugon; A Bonet-Kerrache; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

3.  Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle.

Authors:  D J Law; J G Tidball
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

4.  Dystrophin and a dystrophin-related protein in intrafusal muscle fibers, and neuromuscular and myotendinous junctions.

Authors:  J Zhao; K Yoshioka; M Miyatake; T Miike
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 5.  The membrane hypothesis of Duchenne muscular dystrophy: quest for functional evidence.

Authors:  O F Hutter
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

6.  Gold-labelled dystrophin molecule in muscle plasmalemma of mdx control mice as seen by electron microscopy of deep etching replica.

Authors:  Y Wakayama; S Shibuya
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch.

Authors:  P Moens; P H Baatsen; G Maréchal
Journal:  J Muscle Res Cell Motil       Date:  1993-08       Impact factor: 2.698

8.  Time course study of the isometric contractile properties of mdx mouse striated muscles.

Authors:  C Pastoret; A Sebille
Journal:  J Muscle Res Cell Motil       Date:  1993-08       Impact factor: 2.698

Review 9.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

Review 10.  The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.

Authors:  Jamie L Marshall; Yukwah Kwok; Brian J McMorran; Linda G Baum; Rachelle H Crosbie-Watson
Journal:  FEBS J       Date:  2013-05-13       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.